{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:54:00Z","timestamp":1790927640649,"version":"4.1.0"},"reference-count":32,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2011,8,24]],"date-time":"2011-08-24T00:00:00Z","timestamp":1314144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2012,4]]},"abstract":"<jats:sec>\n                    <jats:label\/>\n                    <jats:p>Study Type \u2013 Therapy (practice patterns cohort)<\/jats:p>\n                    <jats:p>Level of Evidence\u2003not applicable<\/jats:p>\n                    <jats:p>\n                      <jats:bold>What's known on the subject? and What does the study add?<\/jats:bold>\n                    <\/jats:p>\n                    <jats:p>Epidemiological and resistance patterns of bacterial pathogens in urinary tract infections show large inter\u2010regional variability, and rates of bacterial resistance are continually changing due to different regional antibiotic treatment regime. In Ireland and the UK, trimethoprim or nitrofurantoin is usually recommended for empirical treatment of uncomplicated cystitis in the community whilst parenteral cephalosporins, aminoglycosides, quinolones and co\u2010amoxyclav are reserved for complicated UTIs.<\/jats:p>\n                    <jats:p>\n                      Neither penicillins nor trimethoprim represent suitable empirical antimicrobial agents for UTI in this study population. The high rate of ciprofloxacin resistance in encountered is suggestive of an over\u2010reliance on this agent in this population and with resistance rates approaching 30%, empirical use of quinolones for urology patients is inadvisable.\n                      <jats:italic>E.\u2003coli<\/jats:italic>\n                      UTIs have remained extremely sensitive to nitrofurantoin across all three patient sample groups in this population and the resistance rate has not changed significantly over the eleven\u2010year study period.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"explicit-label\">\n                        <jats:list-item>\n                          <jats:p>\n                            To investigate the changing pattern of antimicrobial resistance in Escherichia coli urinary tract infection over an eleven year period, and to determine whether\n                            <jats:italic>E.\u2003coli<\/jats:italic>\n                            antibiotic resistance rates vary depending on whether the UTI represents a nosocomial, community acquired or urology patient specific infection.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENT AND METHODS<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"explicit-label\">\n                        <jats:list-item>\n                          <jats:p>\n                            A retrospective analysis of the 42\u2003033\n                            <jats:italic>E.\u2003coli<\/jats:italic>\n                            urine isolates from the 11\u2010year period 1999\u20132009 in a single Dublin teaching hospital was performed.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            WHONET\n                            <jats:sup>TM<\/jats:sup>\n                            software was used to analyse the changing pattern of sensitivity and resistance of\n                            <jats:italic>E.\u2003coli<\/jats:italic>\n                            to commonly used antibiotics over the study period.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The origins of the urine samples were stratified into three groups: inpatients with nosocomial UTIs; urine originating from the emergency department and general practice (community UTIs); and UTIs in urology patients.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"explicit-label\">\n                        <jats:list-item>\n                          <jats:p>Urinary tract infections in the urology patient population demonstrate higher antibiotic resistance rates than nosocomial or community UTIs.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>There were significant trends of increasing resistance over the 11\u2010year period for ampicillin, trimethoprim, gentamicin and ciprofloxacin, and significant differences in co\u2010amoxyclav, gentamicin, nitrofurantion and ciprofloxacin resistance rates depending on the sample origin.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Ampicillin and trimethoprim were the least active agents against\n                            <jats:italic>E.\u2003coli<\/jats:italic>\n                            , with total 11\u2010year resistance rates of 58.3 and 33.8%, respectively.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            The overall gentamicin resistance rate was 3.4% and is climbing at a rate of 0.7% per year (\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.001). Within the urology patient population the resistance rate was 6.4%.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Ciprofloxacin resistance approaches 20% in the nosocomial UTI population and approaches 30% in the urology population; however, it remains a reasonable empirical antibiotic choice in this community, with an 11\u2010year resistance rate of 10.6%.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"explicit-label\">\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:italic>E.\u2003coli<\/jats:italic>\n                            remains the commonest infecting uropathogen in the community and hospital setting with its incidence climbing from 50 to 60% of UTIs over the 11\u2010year period.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Neither penicillins nor trimethoprim represent suitable empirical antimicrobials for UTI and ciprofloxacin resistance in this Dublin\u2010based study renders it unsuitable empirical therapy for nosocomial UTIs and UTIs in the urology population.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The dramatic 11\u2010year rate increase in gentamicin resistance is of paramount concern.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2011.10528.x","type":"journal-article","created":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T20:27:46Z","timestamp":1314822466000},"page":"1198-1206","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["The changing pattern of antimicrobial resistance within 42\u2003033\n                    <i>Escherichia coli<\/i>\n                    isolates from nosocomial, community and urology patient\u2010specific urinary tract infections, Dublin, 1999\u20132009"],"prefix":"10.1111","volume":"109","author":[{"given":"Ivor M.","family":"Cullen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rustom P.","family":"Manecksha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddie","family":"McCullagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarfraz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fardod","family":"O'Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Grainger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome P.","family":"Fennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Thornhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,8,24]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7323.1197"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg028"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1067\/mda.2003.8"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp030027"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-001-0072-2"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464120-00007"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2010.02.052"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.2.223"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.8.2540-2545.2002"},{"key":"e_1_2_8_11_2","unstructured":"World Health Organization Report on Infectious Diseases 2000. Overcoming Antimicrobial Resistance. Available at:http:\/\/www.who.int\/infectious\u2010disease\u2010report\/2000\/. Accessed 11 December 2010"},{"key":"e_1_2_8_12_2","unstructured":"European Community.A strategy against the microbial threat.Official Journal of the European Community. Council Resolution of 8 June 1999 on antibiotic resistance. Official Journal C 195 13\/07\/1999 pp. 1\u20133. Available at:http:\/\/europa.eu\/rapid\/pressReleasesAction.do?reference=PRES\/99\/185&format=HTML&aged=0&Language=EN&guiLanguage=en. Accessed 11 December 2010"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01057-4"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq286"},{"key":"e_1_2_8_15_2","first-page":"68","article-title":"Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1\u2010year period in Spain","volume":"20","author":"Gobernado M","year":"2007","journal-title":"Rev Esp Quimioter"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.8.736"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-1-200107030-00012"},{"key":"e_1_2_8_18_2","first-page":"735","article-title":"[Summary of the \u2018Urinary tract infections\u2019 guideline (first revision) of the Dutch College of General Practitioners]","volume":"145","author":"Wiersma TJ","year":"2001","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.1.1"},{"key":"e_1_2_8_20_2","volume-title":"Prevention of Hospital Acquired Infections: A Practical Guide","author":"Ducel G","year":"2002"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1086\/339491"},{"key":"e_1_2_8_22_2","unstructured":"EARSS Annual Report 2008. ISBN: 978\u201090\u20106960\u2010236\u20103. Available at:http:\/\/www.rivm.nl\/earss\/result\/Monitoring_reports\/. Accessed 10 December 2011"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/320873"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1157\/13073144"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/592250"},{"key":"e_1_2_8_26_2","doi-asserted-by":"crossref","first-page":"w13059","DOI":"10.4414\/smw.2010.13059","article-title":"Risk factors for urinary tract infections due to ciprofloxacin\u2010resistant Escherichia coli in a tertiary care urology department in Switzerland","volume":"140","author":"Nicoletti J","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl082"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(03)00080-3"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08779.x"},{"key":"e_1_2_8_30_2","first-page":"U1726","article-title":"Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?","volume":"118","author":"Mangin D","year":"2005","journal-title":"N Z Med J"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.02.009"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03168974"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq149"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2011.10528.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2011.10528.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:27:24Z","timestamp":1761748044000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2011.10528.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,24]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.1111\/j.1464-410X.2011.10528.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2011.10528.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,24]]},"assertion":[{"value":"2011-08-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}